Cargando…
Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
In 2015, as part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Chroscinski et al., 2015) that described how we intended to replicate selected experiments from the paper “The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human...
Autor principal: | Horrigan, Stephen K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245970/ https://www.ncbi.nlm.nih.gov/pubmed/28100392 http://dx.doi.org/10.7554/eLife.18173 |
Ejemplares similares
-
Registered report: The CD47-signal regulated protein alpha (SIRPa)
interaction is a therapeutic target for human solid tumors
por: Chroscinski, Denise, et al.
Publicado: (2015) -
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
por: Yang, Hongcheng, et al.
Publicado: (2019) -
Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
por: Sugimura-Nagata, Akane, et al.
Publicado: (2021) -
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition
por: Al-Sudani, Hussein, et al.
Publicado: (2023) -
Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
por: Horrigan, Stephen K, et al.
Publicado: (2017)